K Mitani
Overview
Explore the profile of K Mitani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
274
Citations
2429
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsubura-Okubo M, Komiyama Y, Kamimura R, Sawatani Y, Arai H, Mitani K, et al.
Int J Oral Maxillofac Surg
. 2020 Nov;
50(7):906-914.
PMID: 33144049
The aim of this study was to analyse the effects of gargling with and then swallowing PPAA (polaprezinc in polyacrylic acid solution), in addition to regular oral management, on patients...
2.
Oishi A, Makita N, Manaka K, Mitani K, Tomita H, Iiri T
Diabetol Int
. 2019 Jan;
7(1):95-99.
PMID: 30603249
For elderly hemodialysis patients with diabetes, the treatment options are restricted, and insulin therapy plays an important role. However, sometimes it might be difficult for them to inject insulin by...
3.
Matsuoka H, Uda Y, Mitani K, Yoneyama K, Maeda Y
Biosci Biotechnol Biochem
. 2016 Jun;
60(5):914-5.
PMID: 27281153
An easy preparation method was developed for 3-hydroxymethylene-2-thioxopyrrolidine (TPC), an antimicrobial degradation product of radish pungent principle. The key intermediate, 4- methoxy-3-butenyl-isothiocyanate (MBI), which was prepared from 3-cyanopropionaldehyde dimethyl acetal...
4.
Aoki T, Shimada K, Suzuki R, Izutsu K, Tomita A, Maeda Y, et al.
Blood Cancer J
. 2015 Dec;
5:e372.
PMID: 26636287
No abstract available.
5.
Yamamoto H, Ishimura M, Ochiai M, Takada H, Kusuhara K, Nakatsu Y, et al.
Gene Ther
. 2015 Aug;
23(2):205-13.
PMID: 26280081
X-linked agammaglobulinemia (XLA) is one of the most common humoral immunodeficiencies, which is caused by mutations in Bruton's tyrosine kinase (BTK) gene. To examine the possibility of using gene therapy...
6.
Voutsa D, Anthemidis A, Giakisikli G, Mitani K, Besis A, Tsolakidou A, et al.
Environ Sci Pollut Res Int
. 2015 May;
22(17):13412-26.
PMID: 25940472
The size distribution of total and water-soluble elemental concentrations in six particle sizes <0.49, 0.49-0.97, 0.97-1.5, 1.5-3.0, 3.0-7.2, and 7.2-30 μm was investigated in Thessaloniki area, N. Greece, at two...
7.
Mitani K, Haruyama N, Hatakeyama J, Igarashi K
Oral Dis
. 2012 Aug;
19(2):169-79.
PMID: 22863294
Objective: Amelogenins are the most abundant matrix proteins in enamel. Among the amelogenin isoforms, full-length amelogenin (M180) and leucine-rich amelogenin peptide (LRAP) are expressed in various tissues and are implicated...
8.
Kanai M, Tokunaga T, Miyaji T, Mataki N, Okada C, Mitani K, et al.
Endoscopy
. 2011 Mar;
43 Suppl 2 UCTN:E103-4.
PMID: 21424996
No abstract available.
9.
Kanda Y, Yamashita T, Mori T, Ito T, Tajika K, Mori S, et al.
Bone Marrow Transplant
. 2009 Dec;
45(8):1325-32.
PMID: 19966850
Preemptive therapy is the standard strategy for preventing CMV disease after allogeneic hematopoietic SCT. In this study, unrelated BMT recipients were randomly assigned to a plasma real-time PCR group or...
10.
Matsunami M, Tarui T, Mitani K, Nagasawa K, Fukushima O, Okubo K, et al.
Gut
. 2008 Oct;
58(6):751-61.
PMID: 18852258
Objective: Given recent evidence that hydrogen sulfide (H(2)S), a gasotransmitter, promotes somatic pain through redox modulation of T-type Ca(2+) channels, the roles of colonic luminal H(2)S in visceral nociceptive processing...